Is 255 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 255 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 255 (HK$1.07) is trading below our estimate of fair value (HK$7.34)
Significantly Below Fair Value: 255 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 255?
Key metric: As 255 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 255. This is calculated by dividing 255's market cap by their current
revenue.
What is 255's PS Ratio?
PS Ratio
0.4x
Sales
HK$1.53b
Market Cap
HK$675.89m
255 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
840 Xinjiang Tianye Water Saving Irrigation System
0.04x
n/a
US$14.06m
No more companies available in this PS range
4 Companies
Estimated Growth
Market Cap
No more companies
Price-To-Sales vs Industry: 255 is good value based on its Price-To-Sales Ratio (0.4x) compared to the Hong Kong Machinery industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is 255's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
255 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.4x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 255's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/12/28 17:07
End of Day Share Price
2024/12/27 00:00
Earnings
2024/06/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lung Kee Group Holdings Limited is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst
Institution
Pek Ying Tang
CGS International
Cheuk Yiu Wong
Citigroup Inc
Wesley Yu
Core Pacific -Yamaichi International (H.K.) Limited